Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function

Annual Review of Pharmacology and Toxicology

Volumn 42, Issue , 2002, Pages 409-435

  Angers, Stephane ^a   Salahpour, Ali ^a   Bouvier, Michel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Dimerization; Energy transfer; Signal transduction; Trafficking

Indexed keywords

G PROTEIN COUPLED RECEPTOR; RECEPTOR SUBTYPE;

ANALYTIC METHOD; BIOGENESIS; BIOLUMINESCENCE; COMPLEX FORMATION; DIMERIZATION; ENERGY BALANCE; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; ONTOGENY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SOLUBILIZATION;

ANIMALS; DIMERIZATION; ENDOPLASMIC RETICULUM; ENERGY TRANSFER; FLUORESCENCE; GTP-BINDING PROTEINS; HUMANS; LUMINESCENT MEASUREMENTS; PRECIPITIN TESTS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

HOMO;

EID: 0036174608     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.42.091701.082314     Document Type: Review

References (78)

1. Functional significance of oligomerization of G-protein-coupled receptors
2. A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation
3. Dopamine D2 receptor dimers and receptor-blocking peptides
4. Metabotropic glutamate receptor 5 is a disulfide-linked dimer
5. Dimerization of the delta opioid receptor: Implication for a role in receptor internalization
6. Dimerization of the extracellular calcium-sensing receptor (CAR) on the cell surface of CaR-transfected HEK293 cells
7. Identification and molecular characterization of m3 muscarinic receptor dimers
8. Heterodimerization is required for the formation of a functional GABA(B) receptor
9. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2
10. GABA(B)-receptor subtypes assemble into functional heteromeric complexes
11. G-protein-coupled receptor heterodimerization modulates receptor function
12. Heterodimerization of mu and delta opioid receptors: A role in opiate synergy
13. Oligomerization of muand delta-opioid receptors. Generation of novel functional properties
14. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst3 receptor function by heterodimerization with sst2A
15. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes
16. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
17. Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation
18. Fluorescence techniques: Shedding light on ligand-receptor interactions
19. A bioluminescence resonance energy transfer (BRET) system: Application to interacting circadian clock proteins
20. Detection of beta2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)
21. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: The human delat-opioid receptor displays constitutive oligomerization at the cell surface which is not regulated by receptor occupancy
22. Constitutive and agonist-dependent homooligomerization of the thyrotropin-releasing hormone receptor; detection in living cells using bioluminescence resonance energy transfer
23. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer
24. Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin
25. Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription
26. Spatiotemporal dynamics of guanosine 3′,5′-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator
27. G protein coupled receptors function as oligomers
28. Gonadotropin releasing hormone microaggregation: Rate monitored by fluorescence resonance energy transfer
29. Binding of agonist but not antagonist leads to fluorescence resonance energy transfer between intrinsically fluorescent gonadotropin-releasing hormone receptors
30. Subtypes of the somatostatin receptor assemble as functional
31. Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
32. Luteinizing hormone receptors are self-associated in the plasma membrane
33. Cell signaling by receptor tyrosine kinases
34. Switching signals on or off by receptor dimerization
35. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
36. Erythropoietin receptor activation by a ligand-induced conformation change
37. Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1
38. Assembly, sorting, and exit of oligomeric proteins from the endoplasmic reticulum
39. Role of heteromer formation in GABAB receptor function
40. Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity
41. A trafficking checkpoint controls GABA(B) receptor heterodimerization
42. Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus
43. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function
44. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
45. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
46. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5-delta-32
47. The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors
48. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
49. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin generelated peptide and adrenomedullin receptors in Drosophila Schneider 2 cells
50. Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition
51. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins
52. Heteromeric association creates a P2Y-like adenosine receptor
53. G protein-linked receptors: Pharmacological evidence for the formation of heterodimers
54. The sequence of the human genome
55. Conversion of a gonadotropin-releasing hormone antagonist to an agonist
56. Luteinizing hormone release from dissociated pituitary cells by dimerization of occupied LHRH receptors
57. Synthesis and characterization of bivalent peptide ligands targeted to G-protein-coupled receptors
58. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization
59. From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists
60. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2
61. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization
62. Mapping the agonist-binding site of GABAB type 1 subunit sheds light on the activation process of GABAB receptors
63. The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling
64. C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors
65. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABAB receptor function
66. Mammalian sweet taste receptors
67. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors
68. Polar residues in the transmembrane domain of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by coexpression of two deficient mutants
69. Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function
70. Chemokine control of HIV-1 infection
71. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
72. PAR3 is a cofactor for PAR4 activation by thrombin
73. Immunological identification of A1 adenosine receptors in brain cortex
74. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway
75. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells
76. G-protein-coupled receptor heterodimerization modulates receptor function
77. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
78. Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action